We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report.
This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.
| Behavioral Health Care | ||
| Acquirer | Target | Price |
| Periscope Equity LLC | Integrated Behavioral Health | N/A |
| InTandem Capital Partners LLC | Turning Point Centers | N/A |
| Biotechnology | ||
| Acquirer | Target | Price |
| Provention Bio, Inc. | 2 clinical-stage autoimmune assets | N/A |
| PharmaResearch Products Ltd. | Global commercial license to PXL01 | N/A |
| Eli Lilly and Company | ARMO BioSciences, Inc. | $1.6 billion |
| eHealth | ||
| Acquirer | Target | Price |
| PrescribeWellness | VoicePort’s pharmacy-related assets | N/A |
| TELUS Health | Symbility Health division | $12.8 million |
| Home Health Care & Hospice | ||
| Acquirer | Target | Price |
| Aveanna Healthcare | Premier Healthcare Services, LLC | N/A |
| Hospitals | ||
| Acquirer | Target | Price |
| Global Medical REIT Inc. | City Hospital at White Rock | $23 million |
| Northwestern Memorial HealthCare | Centegra Health System | Merger |
| Laboratories, MRI and Dialysis | ||
| Acquirer | Target | Price |
| Eurofins Scientific | PHAST Gesellschaft fur Pharmazeutische Qualitatsstandards mbH | N/A |
| Managed Care | ||
| Acquirer | Target | Price |
| Integrity Marketing Group, LLC
|
GoldenCare USA, Inc. | N/A |
| Medical Devices | ||
| Acquirer | Target | Price |
| The Riverside Company | DoseLogix | N/A |
| Pharmaceuticals | ||
| Acquirer | Target | Price |
| Takeda Pharmaceutical Company Limited | Shire plc | $81.5 million |
| Lannett Company, Inc. | Portfolio of 24 generic products | N/A |
| Luye Pharma Group Ltd. | Rights to Seroquel | $33.1 million |
| Astellas Pharma, Inc. | Exclusive license to rosiptor in Japan | $250 million |
| Physician Medical Groups | ||
| Acquirer | Target | Price |
| Spectrum Medical Partners, Inc. | Cape Coral Hospitalists, Inc. | N/A |
| Other | ||
| Acquirer | Target | Price |
| CVS Health Corporation | EntrustRx Specialty Pharmacy assets | $40 million |
| NewSpring Capital | vybe urgent care | N/A |
